Pharma Contract Manufacturing 2025 Content Round Up
Welcome to this week's Pharma IQ's newsletter. With less than a month to go before Pharma Contract Manufacturing 2025 in Berlin, we wanted to make sure you hadn't missed out on any valuable content.
We have received great feedback from industry professionals who have read our leading industry reports and interviews ahead of Pharma Contract Manufacturing 2025. To ensure that you haven't missed any of our exclusive content that will help you in your pharma-manufacturing operations today, we have created a content round-up for you.
Understanding the Future of the Pharma Contract Manufacturing Market: 2025 Market Report
This resource provides actionable insights for industry professionals navigating the complexities of pharmaceutical manufacturing. From building resilient supply chains to achieving sustainability goals, the report serves as a roadmap for optimising partnerships, operations, and compliance.
Strategies for Effective Pharma-CMO Partnerships: Insights from Maik Talarczyk, Sandoz
Effective partnerships require a nuanced approach that balances efficiency, flexibility, and alignment on quality standards. In this exclusive interview, Maik Talarczyk shares his insights on managing complexity, fostering resilient partnerships, and future-proofing collaborations with CMOs.
Optimising CDMO Pricing: Strategies for Competitive and Sustainable Success
Pricing strategies in the CDMO landscape are critical to building sustainable, profitable partnerships with pharmaceutical companies. From addressing challenges in value-based pricing to leveraging data analytics, partners Kyriakos Kansos and George Ntortas of Fuliginous Management Consulting share their expert insights on crafting effective pricing models.
Join us at Pharma Contract Manufacturing this March (26-27th) to dive deeper into these topics. For more information on our sessions, download the agenda here.
Kind regards,
The Pharma IQ Team